Meyka Pro banner
Bayer Aktiengesellschaft

Bayer Aktiengesellschaft (SIX: BAYN.SW) Stock Forecast 2027, 2031 & 7-Year Price Prediction

Get the latest Bayer Aktiengesellschaft (SIX: BAYN.SW) stock forecast across short-term and long-term horizons for its SIX listing. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

BAYN.SW●SIX
HealthcareDrug Manufacturers - General
CHF46.34
CHF0.00(0.00%)
Swiss Market opens in 0h 15m

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted PriceCHF30.24
Change↓ CHF-16.10 (-34.74%)

Quarterly Forecast

Predicted PriceCHF43.88
Change↓ CHF-2.46 (-5.31%)

Yearly Forecast

Predicted PriceCHF39.98
Change↓ CHF-6.36 (-13.73%)

3 Years Forecast

Predicted PriceCHF24.10
Change↓ CHF-22.24 (-48.00%)

5 Years Forecast

Predicted PriceCHF8.02
Change↓ CHF-38.32 (-82.70%)

7 Years Forecast

Predicted PriceCHF0.00
Change↓ CHF-46.34 (-100.00%)

Bayer Aktiengesellschaft Stock Forecast Summary

Bayer Aktiengesellschaft (BAYN.SW) stock is currently priced at $46.34. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $30.24.

In the long term, BAYN.SW shows a bearish trend. The 2027 forecast points to $39.98 (-13.73% change), while the 2031 forecast suggests $8.02 (-82.70% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.

Overall Sentiment

Bearish

Short-Term Outlook

Bearish

Long-Term Outlook

Bearish

This mix indicates that Bayer Aktiengesellschaft stock is expected to face downside risk over the coming years.

Investment Calculator

Estimate your potential returns on BAYN.SW using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of €1,000.00 in Bayer Aktiengesellschaft and holding until October 23rd, 2027, you could face a potential €137.26 loss, reflecting a -13.7% ROI over the next 365 days. These projections help you better understand short-term market movements.

€

$Shares Bought

21.5796

@ €46.34/share

~Forecast Price

€39.98

1-year AI forecast

$Est. Portfolio Value

€862.74

€137.26 loss

%ROI

-13.7%

return on investment

Bayer Aktiengesellschaft yearly Price Forecast Chart

Explore the yearly forecast chart for BAYN.SW, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Bayer Aktiengesellschaft over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for BAYN.SWForecasting details for BAYN.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Bayer Aktiengesellschaft Stock Forecast 2026

The forecast for Bayer Aktiengesellschaft (BAYN.SW) in 2026 suggests a price of $39.98, representing a -13.73% move from today’s price.

Average Target: $39.98

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Bayer Aktiengesellschaft Stock Forecast 2030

By 2030, Meyka AI projects BAYN.SW could trade near $8.02, showing a potential -82.70% compared to current levels.

Average Target: $8.02

Market Outlook: bearish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Bayer Aktiengesellschaft.

Frequently Asked Questions